Shopping Cart
- Remove All
Your shopping cart is currently empty
Bevenopran (CB-5945) is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $59 | In Stock | |
| 5 mg | $139 | In Stock | |
| 10 mg | $208 | In Stock | |
| 25 mg | $333 | In Stock | |
| 50 mg | $453 | In Stock | |
| 100 mg | $592 | In Stock | |
| 200 mg | $783 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $153 | In Stock |
| Description | Bevenopran (CB-5945) is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction. |
| In vivo | Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively[1]. |
| Synonyms | CB-5945, ADL-5945 |
| Molecular Weight | 386.44 |
| Formula | C20H26N4O4 |
| Cas No. | 676500-67-7 |
| Smiles | COc1cc(CNCCC2CCOCC2)ccc1Oc1cnc(cn1)C(N)=O |
| Relative Density. | 1.204 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 120 mg/mL (310.53 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.